Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot trial of ilofotase alfa in adult hypophosphatasia
NCT05890794Phase 2Completed
- Sponsor
- AM-Pharma
- Start
- May 2023
- Primary completion
- Jul 2023
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ilofotase alfa in hypophosphatasia (HPP), sponsored by AM-Pharma. Started May 2023; status: completed.
02
Drugs
ilofotase alfa
03
Conditions
hypophosphatasia (HPP)
Beyond the preview
Go deeper on NCT05890794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05890794.